We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Quantum Immunologics Announces Appointment of Dr George Peoples to Scientific Advisory Board
News

Quantum Immunologics Announces Appointment of Dr George Peoples to Scientific Advisory Board

Quantum Immunologics Announces Appointment of Dr George Peoples to Scientific Advisory Board
News

Quantum Immunologics Announces Appointment of Dr George Peoples to Scientific Advisory Board

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Quantum Immunologics Announces Appointment of Dr George Peoples to Scientific Advisory Board"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Dr Johnson stated: "The appointment of Dr Peoples represents a significant milestone in development of our clinical programs at Quantum. Dr Peoples has had extensive experience in overseeing clinical trials including those with cancer vaccines such as ours and his expertise will be invaluable moving forward in clinical development. We look forward to working with Dr Peoples on this important phase of drug development."

Quantum Immunologics is dedicated to the research, development and production of products and services that will promote unique, individualized immunologic cancer treatment and early detection technologies.

Dr Peoples stated: "I am excited by the opportunity to assist Quantum with their clinical development program as we share the belief that the recruitment of the patient's own immune system will be the next critical advance in the treatment of cancer."

Advertisement